Production (Stage)
EGF Theramed Health Corp.
EVAHF
$0.026
-$0.021-44.68%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -18.33% | 105.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.33% | 105.13% | |||
| Operating Income | 18.33% | -105.13% | |||
| Income Before Tax | 66.10% | -425.60% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 66.77% | -436.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -76.67% | 1,053.85% | |||
| Net Income | 65.73% | -409.32% | |||
| EBIT | 18.33% | -105.13% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 65.57% | -408.33% | |||
| Normalized Basic EPS | 64.29% | -337.50% | |||
| EPS Diluted | 65.57% | -408.33% | |||
| Normalized Diluted EPS | 64.29% | -337.50% | |||
| Average Basic Shares Outstanding | 0.00% | 0.70% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||